Announcements Trials
Browse Landscape

Phase

Phase 3 3Phase 2 2

Status

Completed 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Conditions

Menorrhagia 2Leiomyoma 2

Interventions

estradiol, norethindrone drug combination 2elagolix 2Norethindrone Acetate 2Estradiol 2vilaprisan 1ulipristal 1Progesterone 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Menorrhagia × Norethindrone Acetate × Clear all
NCT01441635 2021-07-13

Safety and Efficacy of Elagolix in Pre-Menopausal Women With Heavy Uterine Bleeding and Uterine Fibroids

AbbVie

Phase 2 Completed
271 enrolled 38 charts

Leiomyoma, Menorrhagia

NCT01817530 2020-07-21

Safety and Efficacy in Premenopausal Women With Heavy Menstrual Bleeding (HMB) Associated With Uterine Fibroids (UF)

AbbVie

Phase 2 Completed
571 enrolled 32 charts

Leiomyoma, Menorrhagia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡